Erasca Inc

Erasca’s CMO buys 20,000 shares at $1.70 amid volatility, hinting he sees upside in its KRAS pipeline and IP gains—what it means for investors.

Insider buying fuels optimism for Erasca, as Garner Ebun buys shares under a Rule 10b5‑1 plan and exercises options, showing confidence in the company’s oncology pipeline and potential upside.